Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2023
Immunogenicity of High-Dose Versus MF59-Adjuvanted Versus Standard Influenza Vaccine in Solid Organ Transplant Recipients: The Swiss/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial)Matteo Mombelli, Dionysios Neofytos, Uyen Huynh-Do, et al.
Science (New York, N.Y.)|July 20, 2022
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodiesJun Siong Low, Josipa Jerak, M Alejandra Tortorici, et al.
Biorxiv : the Preprint Server for Biology|April 6, 2021
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (New York, N.Y.)|July 2, 2021
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concernMatthew McCallum, Jessica Bassi, Anna De Marco, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Iscience|December 12, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Science Immunology|January 26, 2023
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoproteinFilippo Bianchini, Virginia Crivelli, Morgan E Abernathy, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease courseJonathan Muri, Valentina Cecchinato, Andrea Cavalli, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Pageof 8